| Authors: |
Baak BN; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands.; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands., de Boer C; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.; Amsterdam UMC location Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam, the Netherlands.; Amsterdam Public Health, Methodology, Amsterdam, the Netherlands., Nooralishahi M; Medisch Centrum Mediport, Amsterdam, the Netherlands., Adolfsen PEA; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands., Lemmens L; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands., van Harten AC; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands., Vijverberg EGB; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands., van der Flier WM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.; Amsterdam UMC location Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam, the Netherlands.; Amsterdam Public Health, Methodology, Amsterdam, the Netherlands., Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands.; Pharmacoepidemiology & Health Care Optimization, Department of Epidemiology & Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands. |